Cargando…
Augmenting Cost-Effectiveness Analysis Will Not Improve Affordability
Autores principales: | Watkins, John B., Tsiao, Emily G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390905/ https://www.ncbi.nlm.nih.gov/pubmed/32223607 http://dx.doi.org/10.18553/jmcp.2020.26.4.407 |
Ejemplares similares
-
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
por: Garrison, Louis P., et al.
Publicado: (2020) -
The cost-effectiveness of 10 antenatal syphilis screening and treatment approaches in Peru, Tanzania, and Zambia
por: Terris-Prestholt, Fern, et al.
Publicado: (2015) -
Linking quality of care and training costs: cost‐effectiveness in health professions education
por: Tolsgaard, Martin G, et al.
Publicado: (2015) -
Costes standard /
por: Bennett, Clinton W.
Publicado: (1967) -
High‐Cost Users of Prescription Drugs: A Population‐Based Analysis from British Columbia, Canada
por: Weymann, Deirdre, et al.
Publicado: (2016)